Pfizer Scraps Daily Weight Loss Pill After Liver Injury | Vantage with Palki Sharma | N18G

Pfizer Scraps Daily Weight Loss Pill After Liver Injury | Vantage with Palki Sharma | N18G

Pfizer has halted development of its potential weight loss pill after a patient suffered liver injury during a trial. The weight loss drug market is projected to hit $150 billion by the early 2030s, with drugs like Ozempic and Wegovy growing in popularity. But concerns about the risks of weight loss drugs remain. How safe are weight loss drugs? How much do we know about them?

---

Pfizer | Weight-Loss Drug | Ozempic | Wegovy | Health | Side Effects | Tirzepatide | Eli Lilly | Mounjaro | Zepbound | Firstpost | World News | Vantage | Palki Sharma

#pfizer #weightlossdrug #tirzepatide #firstpost #vantageonfirstpost #palkisharma #worldnews